title: Partial deletion of chromosome 1 in a case of acute myelocytic leukemia.
abstract: Acute myelocytic leukemia (AML) is a malignant disease characterized by the proliferation of immature myelocytic precursor cells causing the disruption of normal bone marrow function. Many chromosomal aberrations have been described in AML including translocations, inversions, deletions, and additions. Here we describe a novel deletion of chromosome 1, del(1)(p34p36) in a case of AML, French-American-British classification M1, in a previously healthy 33-year-old male. This isolated cytogenetic abnormality occurred in 33% of the myeloblasts examined at diagnosis. Subsequent cytogenetic analyses conducted on marrow following induction and consolidation therapy demonstrated a normal male karyotype in all cells examined. The patient remains in clinical and hematological remission 22 months following diagnosis. The presence of 1p abnormalities in AML and other malignancies is reviewed, as are candidate tumor suppressor genes in the 1p34 approximately p36 region. The implications of chromosome 1p abnormalities on clinical outcome are also discussed.
authors.affiliation: Department of Clinical Haematology, The Canberra Hospital, Garran, Australia. Lucy.Coupland@act.gov.au
authors.forename: L A
authors.initials: LA
authors.lastname: Coupland
authors.forename: V
authors.initials: V
authors.lastname: Jammu
authors.forename: M E
authors.initials: ME
authors.lastname: Pidcock
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008297:Male; D013997:Time Factors; D016896:Treatment Outcome